메뉴 건너뛰기




Volumn 38, Issue 9, 2009, Pages 673-688

Varicella zoster virus: Review of its management

Author keywords

Antiviral; Oral; Perioral; Therapy; VZV

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ALPHA INTERFERON; AMITRIPTYLINE; ANTIVIRUS AGENT; CAPSAICIN; CHICKENPOX VACCINE; DESIPRAMINE; FAMCICLOVIR; FOSCARNET; FOSCARNET SODIUM; GABAPENTIN; HERPES ZOSTER IMMUNOGLOBULIN; LORAZEPAM; MAPROTILINE; METHADONE; MORPHINE; NORTRIPTYLINE; OPIATE; OXCARBAZEPINE; OXYCODONE; PENCICLOVIR; PLACEBO; PREGABALIN; SORIVUDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALACICLOVIR; VALPROATE SEMISODIUM; VIDARABINE; ZIMELDINE; ZOSTEX;

EID: 70350302956     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00802.x     Document Type: Review
Times cited : (34)

References (143)
  • 1
    • 47649086580 scopus 로고    scopus 로고
    • Varicella zoster virus infection: Clinical features, molecular pathogenesis of disease, and latency
    • Mueller NH, Gilden DH, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neuro Clin 2008; 26: 675-697
    • (2008) Neuro Clin , vol.26 , pp. 675-697
    • Mueller, N.H.1    Gilden, D.H.2    Cohrs, R.J.3    Mahalingam, R.4    Nagel, M.A.5
  • 2
    • 35248835968 scopus 로고    scopus 로고
    • The neurotropic herpes viruses: herpes simplex and varicella-zoster
    • Steiner I, Kennedy PG, Pachner AR. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 2007; 6: 1015-1028
    • (2007) Lancet Neurol , vol.6 , pp. 1015-1028
    • Steiner, I.1    Kennedy, P.G.2    Pachner, A.R.3
  • 3
    • 0019906763 scopus 로고
    • Mechanism of action and selectivity of acyclovir
    • Elion GB. Mechanism of action and selectivity of acyclovir. Am J Med 1982; 73: 7-13.
    • (1982) Am J Med , vol.73 , pp. 7-13
    • Elion, G.B.1
  • 4
    • 0033009207 scopus 로고    scopus 로고
    • Current pharmacological approaches to the therapy of varicella zoster virus infections: A guide to treatment
    • Snoeck R, Andrei G, De CE. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment. Drugs 1999; 57: 187-206.
    • (1999) Drugs , vol.57 , pp. 187-206
    • Snoeck, R.1    Andrei, G.2    De, C.E.3
  • 5
    • 0345724848 scopus 로고    scopus 로고
    • Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections
    • Enright AM, Prober C. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections. Herpes 2003; 10: 32-37
    • (2003) Herpes , vol.10 , pp. 32-37
    • Enright, A.M.1    Prober, C.2
  • 6
    • 0028080413 scopus 로고
    • Acyclovir neurotoxicity: Clinical experience and review of the literature
    • Adair JC, Gold M, Bond RE. Acyclovir neurotoxicity: clinical experience and review of the literature. South Med J 1994; 87: 1227-1231
    • (1994) South Med J , vol.87 , pp. 1227-1231
    • Adair, J.C.1    Gold, M.2    Bond, R.E.3
  • 7
    • 0033802435 scopus 로고    scopus 로고
    • Treatment of varicella-zoster virus and postherpetic neuralgia
    • Carrasco DA, Straten MV, Tyring SK. Treatment of varicella-zoster virus and postherpetic neuralgia. Dermatol Ther 2000; 13: 258-268
    • (2000) Dermatol Ther , vol.13 , pp. 258-268
    • Carrasco, D.A.1    Straten, M.V.2    Tyring, S.K.3
  • 8
    • 0036181597 scopus 로고    scopus 로고
    • Antiviral therapy for varicella and herpes zoster
    • Arvin AM. Antiviral therapy for varicella and herpes zoster. Semin Pediatr Infect Dis 2002; 13: 12-21.
    • (2002) Semin Pediatr Infect Dis , vol.13 , pp. 12-21
    • Arvin, A.M.1
  • 9
    • 0025344962 scopus 로고
    • Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy
    • Linnemann CC Jr, Biron KK, Hoppenjans WG, Solinger AM. Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy. AIDS 1990; 4: 577-579
    • (1990) AIDS , vol.4 , pp. 577-579
    • Linnemann Jr., C.C.1    Biron, K.K.2    Hoppenjans, W.G.3    Solinger, A.M.4
  • 12
    • 38649141489 scopus 로고    scopus 로고
    • Nonsteroidal antiinflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease
    • Mikaeloff Y, Kezouh A, Suissa S. Nonsteroidal antiinflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol 2008; 65: 203-209
    • (2008) Br J Clin Pharmacol , vol.65 , pp. 203-209
    • Mikaeloff, Y.1    Kezouh, A.2    Suissa, S.3
  • 13
    • 0025278927 scopus 로고
    • Acyclovir treatment of varicella in otherwise healthy children
    • Balfour HH Jr, Kelly JM, Suarez CS, et al. Acyclovir treatment of varicella in otherwise healthy children. J Pediatr 1990; 116: 633-639
    • (1990) J Pediatr , vol.116 , pp. 633-639
    • Balfour Jr., H.H.1    Kelly, J.M.2    Suarez, C.S.3
  • 14
    • 0026410702 scopus 로고
    • A controlled trial of acyclovir for chickenpox in normal children
    • Dunkle LM, Arvin AM, Whitley RJ, et al. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med 1991; 325: 1539-1544
    • (1991) N Engl J Med , vol.325 , pp. 1539-1544
    • Dunkle, L.M.1    Arvin, A.M.2    Whitley, R.J.3
  • 15
    • 0026511362 scopus 로고
    • Acyclovir treatment of varicella in otherwise healthy adolescents
    • The Collaborative Acyclovir Varicella Study Group
    • Balfour HH Jr, Rotbart HA, Feldman S, et al. Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr 1992; 120: 627-633
    • (1992) J Pediatr , vol.120 , pp. 627-633
    • Balfour Jr., H.H.1    Rotbart, H.A.2    Feldman, S.3
  • 17
    • 0025028711 scopus 로고
    • Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: Retrospective controlled study and review
    • Haake DA, Zakowski PC, Haake DL, Bryson YJ. Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review. Rev Infect Dis 1990; 12: 788-798
    • (1990) Rev Infect Dis , vol.12 , pp. 788-798
    • Haake, D.A.1    Zakowski, P.C.2    Haake, D.L.3    Bryson, Y.J.4
  • 18
    • 0027392764 scopus 로고
    • Immune responses to varicella zoster virus infections in healthy children
    • Rotbart HA, Levin MJ, Hayward AR. Immune responses to varicella zoster virus infections in healthy children. J Infect Dis 1993; 167: 195-199
    • (1993) J Infect Dis , vol.167 , pp. 195-199
    • Rotbart, H.A.1    Levin, M.J.2    Hayward, A.R.3
  • 19
    • 0141742648 scopus 로고    scopus 로고
    • Spread of varicella-zoster virus DNA to the environment from varicella patients who were treated with oral acyclovir
    • Suzuki K, Yoshikawa T, Ihira M, Ohashi M, Suga S, Asano Y. Spread of varicella-zoster virus DNA to the environment from varicella patients who were treated with oral acyclovir. Pediatr Int 2003; 45: 458-460
    • (2003) Pediatr Int , vol.45 , pp. 458-460
    • Suzuki, K.1    Yoshikawa, T.2    Ihira, M.3    Ohashi, M.4    Suga, S.5    Asano, Y.6
  • 20
    • 70350275497 scopus 로고    scopus 로고
    • American Academy of Pediatrics. Varicella zoster virus. In: Pickering LK, ed. EIK Grove Village, IL, American Academy of Pediatrics
    • American Academy of Pediatrics. Varicella zoster virus. In: Pickering LK, ed. 2003 Red book: report of committee on infectious disease, 26th edn. EIK Grove Village, IL: American Academy of Pediatrics, 2003; 672-686
    • (2003) Red book: Report of Committee on Infectious Disease, 26th Edn. , vol.2003 , pp. 672-686
  • 21
    • 0029897575 scopus 로고    scopus 로고
    • Treatment of adult varicella with sorivudine: A randomized, placebo-controlled trial
    • Wallace MR, Chamberlin CJ, Sawyer MH, et al. Treatment of adult varicella with sorivudine: a randomized, placebo-controlled trial. J Infect Dis 1996; 174: 249-255
    • (1996) J Infect Dis , vol.174 , pp. 249-255
    • Wallace, M.R.1    Chamberlin, C.J.2    Sawyer, M.H.3
  • 22
    • 0019946436 scopus 로고
    • Acyclovir therapy of chickenpox in immunosuppressed children: A collaborative study
    • Prober CG, Kirk LE, Keeney RE. Acyclovir therapy of chickenpox in immunosuppressed children: a collaborative study. J Pediatr 1982; 101: 622-625
    • (1982) J Pediatr , vol.101 , pp. 622-625
    • Prober, C.G.1    Kirk, L.E.2    Keeney, R.E.3
  • 23
    • 0033250162 scopus 로고    scopus 로고
    • Approaches to treatment of varicella-zoster virus infection
    • Whitley RJ. Approaches to treatment of varicella-zoster virus infection. Contrib Microbiol 1999; 2: 158-172
    • (1999) Contrib Microbiol , vol.2 , pp. 158-172
    • Whitley, R.J.1
  • 24
    • 0019941684 scopus 로고
    • Vidarabine therapy of varicella in immunosuppressed patients
    • Whitley RJ, Hilty M, Haynes R, et al. Vidarabine therapy of varicella in immunosuppressed patients. J Pediatr 1982; 1: 125-131
    • (1982) J Pediatr , vol.1 , pp. 125-131
    • Whitley, R.J.1    Hilty, M.2    Haynes, R.3
  • 25
    • 0023182240 scopus 로고
    • Varicella in children with cancer: Impact of antiviral therapy and prophylaxis
    • Feldman S, Lott L. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 1987; 80: 465-472
    • (1987) Pediatrics , vol.80 , pp. 465-472
    • Feldman, S.1    Lott, L.2
  • 27
    • 0027462112 scopus 로고
    • Chickenpox during pregnancy
    • Gilbert GL. Chickenpox during pregnancy. BMJ 1993; 306: 1079-1080
    • (1993) BMJ , vol.306 , pp. 1079-1080
    • Gilbert, G.L.1
  • 28
    • 17144442585 scopus 로고    scopus 로고
    • Varicella infections in pregnancy and the newborn. A review prepared for the UK advisory group on chickenpox on behalf of the british society for the study of infection
    • Nathwani D, Maclean A, Conway S, Carrington D. Varicella infections inpregnancy and the newborn. A review prepared for the UK Advisory Group on chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998; 36: S59-71.
    • (1998) J Infect , vol.36
    • Nathwani, D.1    Maclean, A.2    Conway, S.3    Carrington, D.4
  • 29
    • 17144455648 scopus 로고    scopus 로고
    • Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK advisory group on chickenpox on behalf of the british society for the study of infection
    • Ogilvie MM. Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998; 36: S31-8.
    • (1998) J Infect , vol.36
    • Ogilvie, M.M.1
  • 30
    • 0033375144 scopus 로고    scopus 로고
    • Varicella infection during pregnancy
    • Grose C. Varicella infection during pregnancy. Herpes 1999; 6: 33-37
    • (1999) Herpes , vol.6 , pp. 33-37
    • Grose, C.1
  • 31
    • 0035911238 scopus 로고    scopus 로고
    • The management of varicellazoster virus exposure and infection in pregnancy and the newborn period. Australasian subgroup in paediatric infectious diseases of the australasian society for infectious diseases
    • Heuchan AM, Isaacs D. The management of varicellazoster virus exposure and infection in pregnancy and the newborn period. Australasian Subgroup in Paediatric Infectious Diseases of the Australasian Society for Infectious Diseases. Med J Aust 2001; 174: 288-292
    • (2001) Med J Aust , vol.174 , pp. 288-292
    • Heuchan, A.M.1    Isaacs, D.2
  • 32
    • 0025718863 scopus 로고
    • Use of acyclovir for varicella pneumonia during pregnancy
    • Smego RA Jr, Asperilla MO. Use of acyclovir for varicella pneumonia during pregnancy. Obstet Gynecol 1991; 78: 1112-1116
    • (1991) Obstet Gynecol , vol.78 , pp. 1112-1116
    • Smego Jr., R.A.1    Asperilla, M.O.2
  • 33
    • 0014694732 scopus 로고
    • Prevention of varicella by zoster immune globulin
    • Brunell PA, Ross A, Miller LH, Kuo B. Prevention of varicella by zoster immune globulin. N Engl J Med 1969; 280: 1191-1194
    • (1969) N Engl J Med , vol.280 , pp. 1191-1194
    • Brunell, P.A.1    Ross, A.2    Miller, L.H.3    Kuo, B.4
  • 34
    • 0022398961 scopus 로고
    • Effect of zoster immunoglobulin for varicella prophylaxis in the newborn
    • Hanngren K, Grandien M, Granstrom G. Effect of zoster immunoglobulin for varicella prophylaxis in the newborn. Scand J Infect Dis 1985; 17: 343-347
    • (1985) Scand J Infect Dis , vol.17 , pp. 343-347
    • Hanngren, K.1    Grandien, M.2    Granstrom, G.3
  • 35
    • 0024334631 scopus 로고
    • Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicellazoster virus
    • Miller E, Cradock-Watson JE, Ridehalgh MK. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicellazoster virus. Lancet 1989; 2: 371-373
    • (1989) Lancet , vol.2 , pp. 371-373
    • Miller, E.1    Cradock-Watson, J.E.2    Ridehalgh, M.K.3
  • 36
    • 0035106430 scopus 로고    scopus 로고
    • Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella
    • Huang YC, Lin TY, Lin YJ, Lien RI, Chou YH. Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella. Eur J Pediatr 2001; 160:91-94
    • (2001) Eur J Pediatr , vol.160 , pp. 91-94
    • Huang, Y.C.1    Lin, T.Y.2    Lin, Y.J.3    Lien, R.I.4    Chou, Y.H.5
  • 37
    • 0021326978 scopus 로고
    • Intravenous acyclovir therapy for varicella in immunocompromised children
    • Balfour HH. Intravenous acyclovir therapy for varicella in immunocompromised children. J Pediatr 1984; 104: 134-136
    • (1984) J Pediatr , vol.104 , pp. 134-136
    • Balfour, H.H.1
  • 38
    • 0037375309 scopus 로고    scopus 로고
    • Herpes zosterguideline of the German Dermatology Society (DDG).
    • Gross G, Schofer H, Wassilew S, et al. Herpes zosterguideline of the German Dermatology Society (DDG). J Clin Virol 2003; 26: 277-289
    • (2003) J Clin Virol , vol.26 , pp. 277-289
    • Gross, G.1    Schofer, H.2    Wassilew, S.3
  • 39
    • 0036682163 scopus 로고    scopus 로고
    • Clinical practice. Herpes zoster
    • Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002; 347: 340-346
    • (2002) N Engl J Med , vol.347 , pp. 340-346
    • Gnann Jr., J.W.1    Whitley, R.J.2
  • 40
    • 0027494620 scopus 로고
    • Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia
    • King RB. Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia. Arch Neurol 1993; 50: 1046-1053
    • (1993) Arch Neurol , vol.50 , pp. 1046-1053
    • King, R.B.1
  • 41
    • 0035873706 scopus 로고    scopus 로고
    • Herpes zoster in older adults
    • Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001; 32: 1481-1486
    • (2001) Clin Infect Dis , vol.32 , pp. 1481-1486
    • Schmader, K.1
  • 42
    • 0034254888 scopus 로고    scopus 로고
    • The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia
    • Wu CL, Marsh A, Dworkin RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain 2000; 87: 121-129
    • (2000) Pain , vol.87 , pp. 121-129
    • Wu, C.L.1    Marsh, A.2    Dworkin, R.H.3
  • 43
    • 0345724844 scopus 로고    scopus 로고
    • Herpes zoster in the immunocompetent patient: management of post-herpetic neuralgia
    • Johnson RW. Herpes zoster in the immunocompetent patient: management of post-herpetic neuralgia. Herpes 2003; 10: 38-45.
    • (2003) Herpes , vol.10 , pp. 38-45
    • Johnson, R.W.1
  • 44
    • 0022387071 scopus 로고
    • Treatment of herpes zoster with syptomatic nerve block
    • Tenicela R, Lovaski D, Eaglstein W. Treatment of herpes zoster with syptomatic nerve block. Clin J Pain 1985; 1: 63-67
    • (1985) Clin J Pain , vol.1 , pp. 63-67
    • Tenicela, R.1    Lovaski, D.2    Eaglstein, W.3
  • 45
    • 16344393695 scopus 로고    scopus 로고
    • Relief of pain in acute herpes zoster by nerve blocks and possible prevention of post-herpetic neuralgia
    • Hardy D. Relief of pain in acute herpes zoster by nerve blocks and possible prevention of post-herpetic neuralgia. Can J Anaesth 2005; 52: 186-190
    • (2005) Can J Anaesth , vol.52 , pp. 186-190
    • Hardy, D.1
  • 46
    • 0027454126 scopus 로고
    • Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: Clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit
    • Winnie AP, Hartwell PW. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth 1993; 18: 277-282
    • (1993) Reg Anesth , vol.18 , pp. 277-282
    • Winnie, A.P.1    Hartwell, P.W.2
  • 47
    • 0030913752 scopus 로고    scopus 로고
    • The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: A randomized, double-blind, placebo-controlled trial
    • Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 1997; 13: 327-331
    • (1997) J Pain Symptom Manage , vol.13 , pp. 327-331
    • Bowsher, D.1
  • 48
    • 0033857588 scopus 로고    scopus 로고
    • Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone
    • Pasqualucci A, Pasqualucci V, Galla F, et al. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand 2000; 44: 910-918
    • (2000) Acta Anaesthesiol Scand , vol.44 , pp. 910-918
    • Pasqualucci, A.1    Pasqualucci, V.2    Galla, F.3
  • 51
    • 0022474659 scopus 로고
    • Oral acyclovir in the treatment of acute herpes zoster ophthalmicus
    • Cobo LM, Foulks GN, Liesegang T, et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology 1986; 93: 763-770
    • (1986) Ophthalmology , vol.93 , pp. 763-770
    • Cobo, L.M.1    Foulks, G.N.2    Liesegang, T.3
  • 52
    • 0025762995 scopus 로고
    • Oral acyclovir in herpes zoster ophthalmicus
    • Harding SP, Porter SM. Oral acyclovir in herpes zoster ophthalmicus. Curr Eye Res 1991; 10: S177-82.
    • (1991) Curr Eye Res , vol.10
    • Harding, S.P.1    Porter, S.M.2
  • 53
    • 0030063252 scopus 로고    scopus 로고
    • Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta-analysis of placebocontrolled trials
    • Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebocontrolled trials. Clin Infect Dis 1996; 22: 341-347
    • (1996) Clin Infect Dis , vol.22 , pp. 341-347
    • Wood, M.J.1    Kay, R.2    Dworkin, R.H.3    Soong, S.J.4    Whitley, R.J.5
  • 54
    • 0024498188 scopus 로고
    • Lack of effect of acyclovir on postherpetic neuralgia
    • McKendrick MW, McGill JI, Wood MJ. Lack of effect of acyclovir on postherpetic neuralgia. BMJ 1989; 298 431.
    • (1989) BMJ , vol.29 , pp. 431
    • McKendrick, M.W.1    McGill, J.I.2    Wood, M.J.3
  • 55
    • 0027757640 scopus 로고
    • Effect of oral acyclovir on pain resolution in herpes zoster: A reanalysis
    • Huff JC, Drucker JL, Clemmer A, et al. Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol 1993; S1: S93-6.
    • (1993) J Med Virol , vol.S1
    • Huff, J.C.1    Drucker, J.L.2    Clemmer, A.3
  • 56
    • 0031397092 scopus 로고    scopus 로고
    • The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis
    • Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis. Arch Intern Med 1997; 157: 909-912
    • (1997) Arch Intern Med , vol.157 , pp. 909-912
    • Jackson, J.L.1    Gibbons, R.2    Meyer, G.3    Inouye, L.4
  • 57
    • 0028212914 scopus 로고
    • A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster
    • Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330: 896-900.
    • (1994) N Engl J Med , vol.330 , pp. 896-900
    • Wood, M.J.1    Johnson, R.W.2    McKendrick, M.W.3    Taylor, J.4    Mandal, B.K.5    Crooks, J.6
  • 58
    • 0030240530 scopus 로고    scopus 로고
    • Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group
    • Whitley RJ, Weiss H, Gnann JW, et al. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996; 125: 376-383
    • (1996) Ann Intern Med , vol.125 , pp. 376-383
    • Whitley, R.J.1    Weiss, H.2    Gnann, J.W.3
  • 59
    • 0027768955 scopus 로고
    • Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers
    • Weller S, Blum MR, Doucette M, et al. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 1993; 54: 595-605.
    • (1993) Clin Pharmacol Ther , vol.54 , pp. 595-605
    • Weller, S.1    Blum, M.R.2    Doucette, M.3
  • 61
    • 0033773885 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus
    • Colin J, Prisant O, Cochener B, Lescale O, Rolland B, Hoang-Xuan T. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Ophthalmology 2000; 107: 1507-1511
    • (2000) Ophthalmology , vol.107 , pp. 1507-1511
    • Colin, J.1    Prisant, O.2    Cochener, B.3    Lescale, O.4    Rolland, B.5    Hoang-Xuan, T.6
  • 62
    • 0034947673 scopus 로고    scopus 로고
    • Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster
    • Lin WR, Lin HH, Lee SS, et al. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster. J Microbiol Immunol Infect 2001; 34: 138-142
    • (2001) J Microbiol Immunol Infect , vol.34 , pp. 138-142
    • Lin, W.R.1    Lin, H.H.2    Lee, S.S.3
  • 63
    • 0029113580 scopus 로고
    • Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group
    • Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995; 123: 89-96.
    • (1995) Ann Intern Med , vol.123 , pp. 89-96
    • Tyring, S.1    Barbarash, R.A.2    Nahlik, J.E.3
  • 64
    • 0028028038 scopus 로고
    • Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients
    • Degreef H. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Int J Antimicrob Agents 1994; 4: 241-246
    • (1994) Int J Antimicrob Agents , vol.4 , pp. 241-246
    • Degreef, H.1
  • 65
    • 3042664087 scopus 로고    scopus 로고
    • Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster
    • Shen MC, Lin HH, Lee SS, Chen YS, Chiang PC, Liu YC. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster. J Microbiol Immunol Infect 2004; 37: 75-81.
    • (2004) J Microbiol Immunol Infect , vol.37 , pp. 75-81
    • Shen, M.C.1    Lin, H.H.2    Lee, S.S.3    Chen, Y.S.4    Chiang, P.C.5    Liu, Y.C.6
  • 66
    • 1442286419 scopus 로고    scopus 로고
    • Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial
    • Shafran SD, Tyring SK, Ashton R, et al. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial. J Clin Virol 2004; 29: 248-253
    • (2004) J Clin Virol , vol.29 , pp. 248-253
    • Shafran, S.D.1    Tyring, S.K.2    Ashton, R.3
  • 67
    • 0033793287 scopus 로고    scopus 로고
    • Antiviral therapy for herpes zoster: Randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older
    • Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 2000; 9: 863-869
    • (2000) Arch Fam Med , vol.9 , pp. 863-869
    • Tyring, S.K.1    Beutner, K.R.2    Tucker, B.A.3    Anderson, W.C.4    Crooks, R.J.5
  • 68
    • 10344261492 scopus 로고    scopus 로고
    • (E)-5-(2-bromovinyl)-2¢-deoxyuridine (BVDU)
    • De Clercq E. (E)-5-(2-bromovinyl)-2¢-deoxyuridine (BVDU). Med Res Rev 2005; 25: 1-20.
    • (2005) Med Res Rev , vol.25 , pp. 1-20
    • De Clercq, E.1
  • 69
    • 0038460859 scopus 로고    scopus 로고
    • Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study
    • Wassilew SW, Wutzler P. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study. Antiviral Res 2003; 59: 49-56.
    • (2003) Antiviral Res , vol.59 , pp. 49-56
    • Wassilew, S.W.1    Wutzler, P.2
  • 70
    • 0038798619 scopus 로고    scopus 로고
    • Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia
    • Wassilew SW, Wutzler P. Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia. Antiviral Res 2003; 59: 57-60.
    • (2003) Antiviral Res , vol.59 , pp. 57-60
    • Wassilew, S.W.1    Wutzler, P.2
  • 71
    • 13944267980 scopus 로고    scopus 로고
    • Brivudin compared with famciclovir in the treatment of herpes zoster: Effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study
    • Wassilew S. Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study. J Eur Acad Dermatol Venereol 2005; 19: 47-55.
    • (2005) J Eur Acad Dermatol Venereol , vol.19 , pp. 47-55
    • Wassilew, S.1
  • 72
    • 0001142379 scopus 로고    scopus 로고
    • Varicella zoster. In: Knipe DM, Howley PM, eds. Philadelphia: Lippincott Williams &Wilkins
    • Arvin AM. Varicella zoster. In: Knipe DM, Howley PM, eds. Fields virology. Philadelphia: Lippincott Williams &Wilkins, 2001; 2731-2767
    • (2001) Fields virology , pp. 2731-2767
    • Arvin, A.M.1
  • 74
    • 43049094029 scopus 로고    scopus 로고
    • Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older
    • Arora A, Mendoza N, Brantley J, Yates B, Dix L, Tyring S. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older. J Infect Dis 2008; 197: 1289-1295
    • (2008) J Infect Dis , vol.197 , pp. 1289-1295
    • Arora, A.1    Mendoza, N.2    Brantley, J.3    Yates, B.4    Dix, L.5    Tyring, S.6
  • 75
    • 0034745159 scopus 로고    scopus 로고
    • A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients
    • Tyring S, Belanger R, Bezwoda W, Ljungman P, Boon R, Saltzman RL. A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients. Cancer Invest 2001; 19: 13-22.
    • (2001) Cancer Invest , vol.19 , pp. 13-22
    • Tyring, S.1    Belanger, R.2    Bezwoda, W.3    Ljungman, P.4    Boon, R.5    Saltzman, R.L.6
  • 76
    • 0022643766 scopus 로고
    • Treatment of varicella-zoster virus infection in severely immunocom-promised patients. A randomized comparison of acyclovir and vidarabine
    • Shepp DH, Dandliker PS, Meyers JD. Treatment of varicella-zoster virus infection in severely immunocom-promised patients. A randomized comparison of acyclovir and vidarabine. N Engl J Med 1986; 314: 208-212
    • (1986) N Engl J Med , vol.314 , pp. 208-212
    • Shepp, D.H.1    Dandliker, P.S.2    Meyers, J.D.3
  • 77
    • 0026504576 scopus 로고
    • Disseminated herpes zoster in the immunocompromised host: A comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group
    • Whitley RJ, Gnann JW, Hinthorn D, et al. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group. J Infect Dis 1992; 165: 450-455
    • (1992) J Infect Dis , vol.165 , pp. 450-455
    • Whitley, R.J.1    Gnann, J.W.2    Hinthorn, D.3
  • 78
    • 0021361194 scopus 로고
    • Oral (E)-5-(2-bromovinyl)-2¢- deoxyuridine treatment of severe herpes zoster in cancer patients
    • Wildiers J, De Clercq E. Oral (E)-5-(2-bromovinyl)-2¢- deoxyuridine treatment of severe herpes zoster in cancer patients. Eur J Cancer Clin Oncol 1984; 20: 471-476
    • (1984) Eur J Cancer Clin Oncol , vol.20 , pp. 471-476
    • Wildiers, J.1    De Clercq, E.2
  • 79
    • 0031981859 scopus 로고    scopus 로고
    • Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group / AIDS Clinical Trials Group, Herpes Zoster Study Group
    • Gnann JW, Crumpacker CS, Lalezari JP, et al. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group / AIDS Clinical Trials Group, Herpes Zoster Study Group. Antimicrob Agents Chemother 1998; 42: 1139-1145
    • (1998) Antimicrob Agents Chemother , vol.42 , pp. 1139-1145
    • Gnann, J.W.1    Crumpacker, C.S.2    Lalezari, J.P.3
  • 80
    • 0029027496 scopus 로고
    • Oral brivudin vs. Intravenous acyclovir in the treatment of herpes zoster immunocompromised patients: A randomized doubleblind trial
    • Wutzler P, De CE, Wutke K, Farber I. Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster immunocompromised patients: a randomized doubleblind trial. J Med Virol 1995; 46: 252-257
    • (1995) J Med Virol , vol.46 , pp. 252-257
    • Wutzler, P.1    De C.E2    Wutke, K.3    Farber, I.4
  • 81
    • 0028049685 scopus 로고
    • Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2¢-deoxyuridine
    • Keizer HJ, De Bruijn EA, Tjaden UR, De CE. Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)- 2¢-deoxyuridine. J Cancer Res Clin Oncol 1994; 120: 545-549
    • (1994) J Cancer Res Clin Oncol , vol.120 , pp. 545-549
    • Keizer, H.J.1    De Bruijn, E.A.2    Tjaden, U.R.3    De, C.E.4
  • 82
    • 0032470250 scopus 로고    scopus 로고
    • A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs
    • Okuda H, Ogura K, Kato A, Takubo H, Watabe T. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs. J Pharmacol Exp Ther 1998; 287: 791-799
    • (1998) J Pharmacol Exp Ther , vol.287 , pp. 791-799
    • Okuda, H.1    Ogura, K.2    Kato, A.3    Takubo, H.4    Watabe, T.5
  • 83
    • 0030951083 scopus 로고    scopus 로고
    • The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster
    • Yan J, Tyring SK, McCrary MM, et al. The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster. Clin Pharmacol Ther 1997; 61: 563-573
    • (1997) Clin Pharmacol Ther , vol.61 , pp. 563-573
    • Yan, J.1    Tyring, S.K.2    McCrary, M.M.3
  • 84
    • 0031858786 scopus 로고    scopus 로고
    • Sorivudine and 5-fluorouracil; a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase
    • Diasio RB. Sorivudine and 5-fluorouracil; a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase. Br J Clin Pharmacol 1998; 46: 1-4.
    • (1998) Br J Clin Pharmacol , vol.46 , pp. 1-4
    • Diasio, R.B.1
  • 85
    • 0034086342 scopus 로고    scopus 로고
    • Treatment of postherpetic neuralgia: an update
    • Kanazi GE, Johnson RW, Dworkin RH. Treatment of postherpetic neuralgia: an update. Drugs 2000; 59: 1113-1126
    • (2000) Drugs , vol.59 , pp. 1113-1126
    • Kanazi, G.E.1    Johnson, R.W.2    Dworkin, R.H.3
  • 86
    • 0037386209 scopus 로고    scopus 로고
    • Treatment and prevention of postherpetic neuralgia
    • Dworkin RH, Schmader KE. Treatment and prevention of postherpetic neuralgia. Clin Infect Dis 2003; 36: 877-882.
    • (2003) Clin Infect Dis , vol.36 , pp. 877-882
    • Dworkin, R.H.1    Schmader, K.E.2
  • 88
    • 2342523953 scopus 로고    scopus 로고
    • Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia
    • Davies PS, Galer BS. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs 2004; 64: 937-947
    • (2004) Drugs , vol.64 , pp. 937-947
    • Davies, P.S.1    Galer, B.S.2
  • 89
    • 0027152099 scopus 로고
    • A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia
    • Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993; 15: 510-526
    • (1993) Clin Ther , vol.15 , pp. 510-526
    • Watson, C.P.1    Tyler, K.L.2    Bickers, D.R.3    Millikan, L.E.4    Smith, S.5    Coleman, E.6
  • 91
    • 0032954053 scopus 로고    scopus 로고
    • Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: Results of an enriched enrollment study
    • Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999; 80: 533-538
    • (1999) Pain , vol.80 , pp. 533-538
    • Galer, B.S.1    Rowbotham, M.C.2    Perander, J.3    Friedman, E.4
  • 92
    • 0034106570 scopus 로고    scopus 로고
    • Lidocaine patch 5%
    • Comer AM, Lamb HM. Lidocaine patch 5%. Drugs 2000; 59: 245-249
    • (2000) Drugs , vol.59 , pp. 245-249
    • Comer, A.M.1    Lamb, H.M.2
  • 93
    • 0036075881 scopus 로고    scopus 로고
    • Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster
    • Campbell BJ, Rowbotham M, Davies PS, Jacob P III, Benowitz NL. Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. J Pharm Sci 2002; 91: 1343-1350
    • (2002) J Pharm Sci , vol.91 , pp. 1343-1350
    • Campbell, B.J.1    Rowbotham, M.2    Davies, P.S.3    Jacob III, P.4    Benowitz, N.L.5
  • 95
    • 0033015097 scopus 로고    scopus 로고
    • Iontophoretic vincristine in the treatment of postherpetic neuralgia: A double-blind, randomized, controlled trial
    • Dowd NP, Day F, Timon D, Cunningham AJ, Brown L. Iontophoretic vincristine in the treatment of postherpetic neuralgia: a double-blind, randomized, controlled trial. J Pain Symptom Manage 1999; 17: 175-180
    • (1999) J Pain Symptom Manage , vol.17 , pp. 175-180
    • Dowd, N.P.1    Day, F.2    Timon, D.3    Cunningham, A.J.4    Brown, L.5
  • 96
    • 0025908944 scopus 로고
    • Pain and allodynia in postherpetic neuralgia: Role of somatic and sympathetic nervous systems
    • Nurmikko T, Wells C, Bowsher D. Pain and allodynia in postherpetic neuralgia: role of somatic and sympathetic nervous systems. Acta Neurol Scand 1991; 84: 146-152
    • (1991) Acta Neurol Scand , vol.84 , pp. 146-152
    • Nurmikko, T.1    Wells, C.2    Bowsher, D.3
  • 97
    • 0032477305 scopus 로고    scopus 로고
    • Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial
    • Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.JAMA 1998; 280: 1837-1842
    • (1998) JAMA , vol.280 , pp. 1837-1842
    • Rowbotham, M.1    Harden, N.2    Stacey, B.3    Bernstein, P.4    Magnus-Miller, L.5
  • 98
    • 0034750718 scopus 로고    scopus 로고
    • Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study
    • Rice AS, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 2001; 94: 215-224
    • (2001) Pain , vol.94 , pp. 215-224
    • Rice, A.S.1    Maton, S.2
  • 99
    • 0036166869 scopus 로고    scopus 로고
    • Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex
    • Fink K, Dooley DJ, Meder WP, et al. Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002; 42: 229-236
    • (2002) Neuropharmacology , Issue.42 , pp. 229-236
    • Fink, K.1    Dooley, D.J.2    Meder, W.P.3
  • 100
    • 0036722633 scopus 로고    scopus 로고
    • Preferential action of gabapentin and pregabalin at P / Qtype voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices
    • Dooley DJ, Donovan CM, Meder WP, Whetzel SZ. Preferential action of gabapentin and pregabalin at P / Qtype voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices. Synapse 2002; 45: 171-190
    • (2002) Synapse , vol.45 , pp. 171-190
    • Dooley, D.J.1    Donovan, C.M.2    Meder, W.P.3    Whetzel, S.Z.4
  • 101
    • 12444288040 scopus 로고    scopus 로고
    • Pregabalin: In the treatment of postherpetic neuralgia
    • Frampton JE, Foster RH. Pregabalin: in the treatment of postherpetic neuralgia. Drugs 2005; 65: 111-118
    • (2005) Drugs , vol.65 , pp. 111-118
    • Frampton, J.E.1    Foster, R.H.2
  • 102
    • 1842734242 scopus 로고    scopus 로고
    • Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial
    • Sabatowski R, Galvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004; 109: 26-35.
    • (2004) Pain , vol.109 , pp. 26-35
    • Sabatowski, R.1    Galvez, R.2    Cherry, D.A.3
  • 103
    • 19444362218 scopus 로고    scopus 로고
    • Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixeddose regimens
    • Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixeddose regimens. Pain 2005; 115: 254-263
    • (2005) Pain , vol.115 , pp. 254-263
    • Freynhagen, R.1    Strojek, K.2    Griesing, T.3    Whalen, E.4    Balkenohl, M.5
  • 104
    • 15044357367 scopus 로고    scopus 로고
    • Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin
    • Criscuolo S, Auletta C, Lippi S, Brogi F, Brogi A. Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin. Acta Neurol Scand 2005; 111: 229-232
    • (2005) Acta Neurol Scand , vol.111 , pp. 229-232
    • Criscuolo, S.1    Auletta, C.2    Lippi, S.3    Brogi, F.4    Brogi, A.5
  • 105
    • 12444259804 scopus 로고    scopus 로고
    • Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study
    • Kochar DK, Garg P, Bumb RA, et al. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. QJM 2005; 98: 29-34.
    • (2005) QJM , vol.98 , pp. 29-34
    • Kochar, D.K.1    Garg, P.2    Bumb, R.A.3
  • 106
    • 0018159356 scopus 로고
    • Endogenous pain control mechanisms: Review and hypothesis
    • Basbaum AI, Fields HL. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 1978; 4: 451-462
    • (1978) Ann Neurol , vol.4 , pp. 451-462
    • Basbaum, A.I.1    Fields, H.L.2
  • 107
    • 0026505452 scopus 로고
    • Amitriptyline versus maprotiline in postherpetic neuralgia: A randomized, double-blind, crossover trial
    • Watson CP, Chipman M, Reed K, Evans RJ, Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992; 48: 29-36.
    • (1992) Pain , vol.48 , pp. 29-36
    • Watson, C.P.1    Chipman, M.2    Reed, K.3    Evans, R.J.4    Birkett, N.5
  • 108
    • 0022347663 scopus 로고
    • A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia
    • Watson CP, Evans RJ. A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia. Pain 1985; 23: 387-394
    • (1985) Pain , vol.23 , pp. 387-394
    • Watson, C.P.1    Evans, R.J.2
  • 110
    • 0031687674 scopus 로고    scopus 로고
    • Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial
    • Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998; 51: 1166-1171
    • (1998) Neurology , vol.51 , pp. 1166-1171
    • Watson, C.P.1    Vernich, L.2    Chipman, M.3    Reed, K.4
  • 112
    • 4744371563 scopus 로고    scopus 로고
    • Treatment of postherpetic neuralgia: A review of therapeutic options
    • Argoff CE, Katz N, Backonja M. Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symptom Manage 2004; 28: 396-411.
    • (2004) J Pain Symptom Manage , vol.28 , pp. 396-411
    • Argoff, C.E.1    Katz, N.2    Backonja, M.3
  • 113
    • 0033826271 scopus 로고    scopus 로고
    • Chronic neuropathic pain: Mechanisms and treatment
    • Attal N. Chronic neuropathic pain: mechanisms and treatment. Clin J Pain 2000; 16: S118-30.
    • (2000) Clin J Pain , vol.16
    • Attal, N.1
  • 114
    • 0031780851 scopus 로고    scopus 로고
    • Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia
    • Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998; 50: 1837-1841
    • (1998) Neurology , vol.50 , pp. 1837-1841
    • Watson, C.P.1    Babul, N.2
  • 115
    • 0037044286 scopus 로고    scopus 로고
    • Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial
    • Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002; 59: 1015-1021
    • (2002) Neurology , vol.59 , pp. 1015-1021
    • Raja, S.N.1    Haythornthwaite, J.A.2    Pappagallo, M.3
  • 116
    • 0034707108 scopus 로고    scopus 로고
    • Intrathecal methylprednisolone for intractable postherpetic neuralgia
    • Kotani N, Kushikata T, Hashimoto H, et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000; 343: 1514-1519
    • (2000) N Engl J Med , vol.343 , pp. 1514-1519
    • Kotani, N.1    Kushikata, T.2    Hashimoto, H.3
  • 117
    • 0016267076 scopus 로고
    • Live vaccine used to prevent the spread of varicella in children in hospital
    • Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974; 2: 1288-1290
    • (1974) Lancet , vol.2 , pp. 1288-1290
    • Takahashi, M.1    Otsuka, T.2    Okuno, Y.3    Asano, Y.4    Yazaki, T.5
  • 118
    • 0037028761 scopus 로고    scopus 로고
    • Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
    • Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002; 287: 606-611
    • JAMA , vol.2002 , Issue.287 , pp. 606-611
    • Seward, J.F.1    Watson, B.M.2    Peterson, C.L.3
  • 120
    • 34250688647 scopus 로고    scopus 로고
    • Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56(RR-4): 1-40.
    • (2007) MMWR Recomm Rep , vol.56 , Issue.RR-4 , pp. 1-40
    • Marin, M.1    Guris, D.2    Chaves, S.S.3    Schmid, S.4    Seward, J.F.5
  • 121
    • 10744231582 scopus 로고    scopus 로고
    • Ten year follow-up of healthy children who received one or two injections of varicella vaccine
    • Kuter B, Matthews H, Shinefield H, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 2004; 23: 132-137
    • (2004) Pediatr Infect Dis J , vol.23 , pp. 132-137
    • Kuter, B.1    Matthews, H.2    Shinefield, H.3
  • 122
    • 0028891001 scopus 로고
    • Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine
    • Watson B, Boardman C, Laufer D, et al. Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine. Clin Infect Dis 1995; 20: 316-319
    • (1995) Clin Infect Dis , vol.20 , pp. 316-319
    • Watson, B.1    Boardman, C.2    Laufer, D.3
  • 123
    • 37349000273 scopus 로고    scopus 로고
    • A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella
    • Ramet J. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella. Int J Infect Dis 2007; 11: S49-55.
    • (2007) Int J Infect Dis , vol.11
    • Ramet, J.1
  • 124
    • 0025762781 scopus 로고    scopus 로고
    • Varicella vaccine (VARIVAX) in healthy children and adolescents: Results from clinical trials, 1987 to 1989
    • White CJ, Kuter BJ, Hildebrand CS, et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics 1991; 87: 604-610
    • Pediatrics , vol.1991 , Issue.87 , pp. 604-610
    • White, C.J.1    Kuter, B.J.2    Hildebrand, C.S.3
  • 125
    • 0028154116 scopus 로고
    • Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine
    • Watson B, Gupta R, Randall T, Starr S. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. J Infect Dis 1994; 169: 197-199
    • (1994) J Infect Dis , vol.169 , pp. 197-199
    • Watson, B.1    Gupta, R.2    Randall, T.3    Starr, S.4
  • 126
    • 0029834560 scopus 로고    scopus 로고
    • Clinical trials of varicella vaccine in healthy adolescents and adults
    • Arbeter AM. Clinical trials of varicella vaccine in healthy adolescents and adults. Infect Dis Clin North Am 1996; 10: 609-615
    • (1996) Infect Dis Clin North Am , vol.10 , pp. 609-615
    • Arbeter, A.M.1
  • 127
    • 0028893033 scopus 로고
    • Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine
    • Nader S, Bergen R, Sharp M, Arvin AM. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. J Infect Dis 1995; 171: 13-17
    • (1995) J Infect Dis , vol.171 , pp. 13-17
    • Nader, S.1    Bergen, R.2    Sharp, M.3    Arvin, A.M.4
  • 128
    • 0025318162 scopus 로고
    • Live attenuated varicella vaccine: Protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group
    • Gershon AA, Steinberg SP. Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. J Infect Dis 1990; 161: 661-666
    • (1990) J Infect Dis , vol.161 , pp. 661-666
    • Gershon, A.A.1    Steinberg, S.P.2
  • 129
    • 84944364667 scopus 로고
    • Live attenuated varicella vaccine. Efficacy for children with leukemia in remission
    • Gershon AA, Steinberg SP, Gelb L, et al. Live attenuated varicella vaccine. Efficacy for children with leukemia in remission. JAMA 1984; 252: 355-362
    • (1984) JAMA , vol.252 , pp. 355-362
    • Gershon, A.A.1    Steinberg, S.P.2    Gelb, L.3
  • 130
    • 0025870301 scopus 로고
    • Oka / Merck varicella vaccine in healthy children: Final report of a 2-year efficacy study and 7-year follow-up studies
    • Kuter BJ, Weibel RE, Guess HA, et al. Oka / Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991; 9: 643-647
    • (1991) Vaccine , vol.9 , pp. 643-647
    • Kuter, B.J.1    Weibel, R.E.2    Guess, H.A.3
  • 131
    • 0029859658 scopus 로고    scopus 로고
    • Efficacy of high-titer live attenuated varicella vaccine in healthy young children
    • Varis T, Vesikari T. Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J Infect Dis 1996; 174: S330-4.
    • (1996) J Infect Dis , vol.174
    • Varis, T.1    Vesikari, T.2
  • 132
    • 0027497481 scopus 로고
    • Modified chickenpox in children immunized with the Oka / Merck varicella vaccine
    • Watson BM, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka / Merck varicella vaccine. Pediatrics 1993; 91: 17-22.
    • (1993) Pediatrics , vol.91 , pp. 17-22
    • Watson, B.M.1    Piercy, S.A.2    Plotkin, S.A.3    Starr, S.E.4
  • 133
    • 0026504601 scopus 로고
    • Modified cases of chickenpox after varicella vaccination: Correlation of protection with antibody response
    • White CJ, Kuter BJ, Ngai A, et al. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response. Pediatr Infect Dis J 1992; 11: 19-23.
    • (1992) Pediatr Infect Dis J , vol.11 , pp. 19-23
    • White, C.J.1    Kuter, B.J.2    Ngai, A.3
  • 135
    • 33745684693 scopus 로고    scopus 로고
    • The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: A study of manufacturing consistency and persistence of antibody
    • Lieberman JM, Williams WR, Miller JM, et al. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody. Pediatr Infect Dis J 2006; 25: 615-622
    • (2006) Pediatr Infect Dis J , vol.25 , pp. 615-622
    • Lieberman, J.M.1    Williams, W.R.2    Miller, J.M.3
  • 136
    • 51649087202 scopus 로고    scopus 로고
    • Varicella prevention in the United States: A review of successes and challenges
    • Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 2008; 122: e744-51.
    • (2008) Pediatrics , vol.122
    • Marin, M.1    Meissner, H.C.2    Seward, J.F.3
  • 137
    • 0034703813 scopus 로고    scopus 로고
    • The postmarketing safety profile of varicella vaccine
    • Sharrar RG, LaRussa P, Galea SA, et al. The postmarketing safety profile of varicella vaccine. Vaccine 2000; 19: 916-923
    • (2000) Vaccine , vol.19 , pp. 916-923
    • Sharrar, R.G.1    LaRussa, P.2    Galea, S.A.3
  • 138
    • 0034644423 scopus 로고    scopus 로고
    • Postlicensure safety surveillance for varicella vaccine
    • Wise RP, Salive ME, Braun MM, et al. Postlicensure safety surveillance for varicella vaccine. JAMA 2000; 284 1271-1279
    • (2000) JAMA , vol.28 , pp. 1271-1279
    • Wise, R.P.1    Salive, M.E.2    Braun, M.M.3
  • 139
    • 0035070245 scopus 로고    scopus 로고
    • Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina
    • Clements DA, Zaref JI, Bland CL, Walter EB, Coplan PM. Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina. Arch Pediatr Adolesc Med 2001; 155: 455-461
    • (2001) Arch Pediatr Adolesc Med , vol.155 , pp. 455-461
    • Clements, D.A.1    Zaref, J.I.2    Bland, C.L.3    Walter, E.B.4    Coplan, P.M.5
  • 140
    • 0026411149 scopus 로고
    • The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella vaccine collaborative study group
    • Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 1991; 325: 1545-1550
    • (1991) N Engl J Med , vol.325 , pp. 1545-1550
    • Hardy, I.1    Gershon, A.A.2    Steinberg, S.P.3    LaRussa, P.4
  • 141
  • 142
    • 0029554637 scopus 로고
    • Immunization to reduce the frequency and severity of herpes zoster and its complications
    • Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 1995; 45: S41-6.
    • (1995) Neurology , vol.45
    • Oxman, M.N.1
  • 143
    • 21144448596 scopus 로고    scopus 로고
    • A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
    • Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-2284.
    • (2005) N Engl J Med , vol.352 , pp. 2271-2284
    • Oxman, M.N.1    Levin, M.J.2    Johnson, G.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.